Abstract:Background Gout is generally considered as an acute or chronic inflammatory disease of the joints due to deposition of crystals of monosodium urate (MSU). However, crystals of MSU do not always elicit inflammation in joints, suggesting that the immunological basis is required for the development of gouty arthritis. Although T helper 17 (Th17) and regulatory T cell subsets in CD4 +T cells have been reported to play a key role in autoimmune diseases, their status in peripheral blood of gout patients are rare studied. Objectives Our present study is to explore whether the absolute numbers of peripheral CD4 +T subsets, especially Th17 cells and CD4 +CD25+FOXP3T regulatory (Treg) cells, is abnormal in gout. Methods A total of 72 patients with gout (70 male/2 female) and 41 age-sexual-matched controls were recruited from the Second Hospital of Shanxi Medical University (from March 1 st in 2016 to July 30th in 2017). Of these, 72 patients were categorised as acute gout who had redness, swelling, warmth and pain at the same time (Group1; n=18) or as acute gout without redness and warmth (Group2; n=52). All patients fulfilled 2015 Gout classification criteria developed by the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR). Patients with a history of other autoimmune diseases, nephropathy, cancer, infectious processes, or hematopathy were excluded. The detail medical histories were collected, comprehensive laboratory examinations were performed, and then the differences between the patients and controls were investigated. The concentrations of CD4 +T cell subsets (the absolute numbers of Th1, Th2, Th17 and Treg cells) in peripheral blood were measured by flow cytometry combined with internal standard beads and then the ratios of Th1/Th2 and Th17/Treg were calculated. Results The duration of their disease was 46.73±54.92 (Group1), or 61.54±70.51 (Group2) months. The white blood cells (WBCs) and neutrophils in gout blood were significantly higher than those in controls (P 0.05). Conclusions The increase of peripheral Th2 and Th17 cells led to an imbalance of CD4 +T cell subsets may correlate with gouty inflammation in an undefined way. The elevation of Th2 and Th17 cells may serve as important reference indices for gout attack and a target of gout treatment. Moreover, Th17 may contribute to the persistence of the disease. Reference [1] Zhou Z, Li X, Li H, Guo M, Liu S, Li C. Genetic Analysis of IL-17 Gene Polymorphisms in Gout in a Male Chinese Han Population. PLoS One [Internet]2016;11(2):e0148082. Disclosure of Interest None declared

IL-33 enhances macrophage release of IL-1β and promotes pain and inflammation in gouty arthritis

IL-33 Ameliorates the Development of MSU-Induced Inflammation Through Expanding MDSCs-Like Cells

IL-33 exacerbates autoantibody-induced arthritis

FRI0239 Absolute numbers of peripheral th17 and th2 cells increased in patients with gout

IL-33 Exacerbates Antigen-Induced Arthritis by Activating Mast Cells

Increased IL-33 in Synovial Fluid and Paired Serum is Associated with Disease Activity and Autoantibodies in Rheumatoid Arthritis

Transmembrane TNF‐α is Sufficient for Articular Inflammation and Hypernociception in a Mouse Model of Gout

Potential of IL-33 for Preventing the Kidney Injury Via Regulating the Lipid Metabolism in Gout Patients.

Interleukin-33 mediates formalin-induced inflammatory pain in mice.

NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout.

Elevated Serum Level of IL-33 and sST2 in Patients With Ankylosing Spondylitis

SERUM LEVEL OF IL-33 IN GOUTY RENAL PATIENTS

Nerve modulation therapy in gouty arthritis: targeting increased sFRP2 expression in dorsal root ganglion regulates macrophage polarization and alleviates endothelial damage

Interleukin-33 is Released in Spinal Cord and Suppresses Experimental Autoimmune Encephalomyelitis in Mice.

IL-33: a promising therapeutic target for rheumatoid arthritis?

Elevated serum level of IL-33 and sST2 in patients with ankylosing spondylitis: associated with disease activity and vascular endothelial growth factor.

Nlrp3 Inflammasome-Mediated Neutrophil Recruitment And Hypernociception Depends On Leukotriene B4 In A Murine Model Of Gout

Interleukin 37 Limits Monosodium Urate Crystal-Induced Innate Immune Responses in Human and Murine Models of Gout

IL-37 Blocks Gouty Inflammation by Shaping Macrophages into a Non-Inflammatory Phagocytic Phenotype.

MicroRNA-223 Suppresses IL-1β and TNF-α Production in Gouty Inflammation by Targeting the NLRP3 Inflammasome

Inhibition of Spinal Interleukin-33 Attenuates Peripheral Inflammation and Hyperalgesia in Experimental Arthritis